Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

17.3K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

14.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on Genetic Chorea.

Current neurology and neuroscience reports·2026
Same author

Repeat expansions in Parkinson's disease and parkinsonism across ancestries: insights from a global genetic cohort.

medRxiv : the preprint server for health sciences·2026
Same author

Large-scale functional annotation establishes a reference framework for human <i>LRRK2</i> variants.

medRxiv : the preprint server for health sciences·2026
Same author

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026
Same author

Haplotype-resolved DNA methylation at the <i>APOE</i> locus identifies allele-specific epigenetic signatures relevant to Alzheimer's disease risk.

NPJ dementia·2026
Same author

iSCORE-PD: an isogenic stem cell collection to research Parkinson's disease.

Nature communications·2026

Related Experiment Video

Updated: Jun 6, 2025

Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

11.6K

CNV-Finder: Streamlining Copy Number Variation Discovery.

Nicole Kuznetsov1,2, Kensuke Daida1, Mary B Makarious1,2,3

  • 1Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Biorxiv : the Preprint Server for Biology
|November 28, 2024
PubMed
Summary
This summary is machine-generated.

CNV-Finder, a novel deep learning pipeline, accurately identifies copy number variations (CNVs) using array data for neurological disease research. This scalable tool expedites large-scale CNV detection, reducing manual workload and enabling efficient sample prioritization for further analysis.

Keywords:
Copy Number Variation (CNV)PythonStructural Variant (SV)deep learninggeneticslong short-term memory (LSTM)pipeline

More Related Videos

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.0K
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.7K

Related Experiment Videos

Last Updated: Jun 6, 2025

Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

11.6K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.0K
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.7K

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Copy Number Variations (CNVs) are crucial in complex disease etiology and population variability.
  • Accurate CNV detection is vital for disease genetics research, often requiring large sample sizes.
  • Illumina genotyping arrays offer cost-effective CNV detection via Log R Ratio (LRR) and B Allele Frequency (BAF).

Purpose of the Study:

  • To develop and validate CNV-Finder, a novel deep learning pipeline for large-scale CNV identification.
  • To expedite the prioritization of samples for subsequent whole genome sequencing analyses.
  • To enhance the accuracy and efficiency of CNV detection in genes associated with neurological diseases.

Main Methods:

  • Integration of deep learning, specifically Long Short-Term Memory (LSTM) networks, with array data (LRR and BAF).
  • Training models on expert-annotated samples and validation across diverse cohorts (e.g., Global Parkinson's Genetics Program).
  • Development of an interactive web application for visualization, review, and filtering of CNV predictions.

Main Results:

  • CNV-Finder accurately detects deletions and duplications, demonstrating efficacy across diverse cohorts.
  • The pipeline successfully identifies CNVs in regions with varied sparsity, noise, and size, including complex regions like 17q21.31.
  • Human feedback integration enhances model performance and reduces false positive rates.

Conclusions:

  • CNV-Finder is a scalable, publicly available resource for efficient and accurate CNV identification.
  • The pipeline significantly reduces manual workload for researchers, facilitating targeted validation and downstream analyses.
  • Contextual understanding and human expertise are key to enhancing CNV identification precision.